ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2024

Evaluation of 1,10-phenanthroline-based hydroxamate derivative as dual histone deacetylases/ribonucleotide reductase inhibitor with antitumor activities.

Manasa Gangadhar Shetty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.